Formulation Development White Papers & Articles

  1. Unlocking The Full Potential Of Antibody-Drug Conjugates (ADCs) 6/15/2026

    ADCs are evolving rapidly. Gain insight into how success now hinges on managing complexity, delivery, and scalability to turn promising designs into viable therapeutic products.

  2. ADC Manufacturing: Practices, Challenges, And The Road Ahead 6/15/2026

    ADCs are advancing quickly, but manufacturing complexity is rising just as fast. Key challenges in scale-up, regulation, and costs are reshaping how the next generation of therapies will be delivered.

  3. Why CDMO Performance Drops Exactly When It Matters Most 6/15/2026

    Programs often stall moving to GMP due to fragmented workflows and knowledge gaps. Aligning teams and integrating development with execution, via continuous data, sustains momentum and reduces risk.

  4. Advanced Process Development And Manufacturing Solutions 6/11/2026

    Scaling complex chemical processes requires early risk identification, integrated safety and analytical expertise, and efficient tech transfer.

  5. The 5-S Philosophy Driving Asymchem's Integrated TIDES Manufacturing 6/11/2026

    Manufacturing excellence drives complex therapies, with scale, speed, supply resilience, sustainability, and future readiness enabling development to reliable commercial production.

  6. Coordinated Development As An Execution Framework 6/9/2026

    See how integrating clinical, development, manufacturing, and supply functions within a single execution framework can transform program performance and accelerate development success.

  7. Closing The QC Gap For mAbs: Rapid Answers Without Compromising 6/9/2026

    Monoclonal antibodies are complex biologics requiring precise analytical strategies to monitor critical quality attributes and impurities, with molecular assays like qPCR supporting sensitive detection, product integrity, and regulatory compliance.

  8. Navigating Regulatory Barriers For CRISPR Gene Editing Therapies 6/9/2026

    Bringing CRISPR therapies to market requires navigating complex global regulations. Learn how strategic planning, risk assessment, and manufacturing alignment can streamline development.

  9. Get More From Less: AMP Chemistry Outperforms Hybrid Capture 6/9/2026

    Sequencing performance can drop quickly with low-quality, low-input FFPE DNA. Gain insight into how one approach helps labs minimize repeats and maintain more consistent results.

  10. Sterilization Of APIs – The Alternative: Sterile Filtration Following Aseptic Processing 5/21/2026

    When terminal sterilization isn't an option for heat- or radiation-sensitive APIs, sterile filtration with aseptic processing protects quality. Get the technical framework.